SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 270 filers reported holding SAGE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $275,000 | +15.5% | 4,500 | +164.7% | 0.01% | 0.0% |
| Q3 2019 | $238,000 | -23.5% | 1,700 | 0.0% | 0.01% | -26.3% |
| Q2 2019 | $311,000 | +15.2% | 1,700 | 0.0% | 0.02% | +11.8% |
| Q1 2019 | $270,000 | +12.5% | 1,700 | 0.0% | 0.02% | +21.4% |
| Q3 2018 | $240,000 | -9.8% | 1,700 | 0.0% | 0.01% | -12.5% |
| Q2 2018 | $266,000 | -2.9% | 1,700 | 0.0% | 0.02% | -5.9% |
| Q1 2018 | $274,000 | -2.1% | 1,700 | 0.0% | 0.02% | -5.6% |
| Q4 2017 | $280,000 | – | 1,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |